Last update 01 Nov 2024
HR-20013
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms 罗拉匹坦(前药)/帕洛诺司琼 + [2] |
Target |
Mechanism 5-HT3A receptor antagonists(5-HT 3a receptor antagonists), NK1R antagonists(Neurokinin 1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC27H29F6N2O8P |
InChIKeyPKXQGSOAMISYFP-LJXNEXSDSA-N |
CAS Registry2573694-38-7 |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chemotherapy-induced nausea and vomiting | NDA/BLA | CN | 14 Dec 2023 | |
| Malignant Solid Neoplasm | Phase 3 | CN | 21 Sep 2022 | |
| Nausea | Phase 3 | CN | 21 Sep 2022 | |
| Nausea and vomiting | Phase 3 | CN | 21 Sep 2022 | |
| Vomiting | Phase 3 | CN | 21 Sep 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 3 | - | HR20013+DEX (Cycle 1) | (mvmhwxzoop) = gbmvdzpsru kzoguddvft (txmwdordgs ) Met View more | Non-inferior | 08 Sep 2024 | ||
FAPR+PALO+DEX (Cycle 1) | (mvmhwxzoop) = nswyeothsd kzoguddvft (txmwdordgs ) Met View more | ||||||
Phase 3 | 750 | HR20013+地塞米松 | csdkxidhuv(yqnwawltim) = qraiwkiesq angkzfgleu (yjgtnievls ) View more | Positive | 08 Jul 2024 | ||
福沙匹坦+帕洛诺司琼+地塞米松 | csdkxidhuv(yqnwawltim) = achzevvtlp angkzfgleu (yjgtnievls ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free